US2016257931A1PendingUtilityA1
Method for culture of corneal endothelial cells, process for production of corneal endothelial cell sheet for transplantation purposes, and culture kit for corneal endothelial cells
Assignee: CORNEA REGENERATION INST CO LTDPriority: Feb 5, 2010Filed: May 18, 2016Published: Sep 8, 2016
Est. expiryFeb 5, 2030(~3.5 yrs left)· nominal 20-yr term from priority
C12N 2501/115C12N 2533/54C12N 5/0621C12N 2500/38
42
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention provides a method of culturing a corneal endothelial cell by use of a culture medium containing an ascorbic acid derivative and the like.
Claims
exact text as granted — not AI-modified1 . A method of proliferating a corneal endothelial cell, comprising culturing a corneal endothelial cell in a culture medium containing ascorbyl 2-phosphate, thereby proliferating a corneal endothelial cell.
2 . The method according to claim 1 , wherein the corneal endothelial cell is cultured on a biopolymer.
3 . The method according to claim 2 , wherein the biopolymer is an extracellular matrix molecule containing collagen.
4 . The method according to claim 3 , wherein the collagen is atelocollagen.
5 . A corneal endothelial cell produced by the method according to claim 1 .
6 . A method of producing a corneal endothelial cell sheet for transplantation, comprising a step of culturing a corneal endothelial cell in a culture medium containing ascorbyl 2-phosphate, thereby producing a corneal endothelial cell sheet for transplantation.
7 . The method according to claim 6 , wherein the corneal endothelial cell is cultured on a biopolymer.
8 . The method according to claim 7 , wherein the biopolymer is an extracellular matrix molecule containing collagen.
9 . The method according to claim 8 , wherein the collagen is atelocollagen.
10 . A corneal endothelial cell sheet for transplantation, which is produced by the method according to claim 6 .
11 . A corneal endothelial cell culture kit comprising a substrate coated with a biopolymer and a culture medium containing an ascorbic acid derivative.Join the waitlist — get patent alerts
Track US2016257931A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.